Langerhans-Cell Histiocytosis

被引:396
作者
Allen, Carl E. [1 ,2 ]
Merad, Miriam [3 ,4 ,5 ]
McClain, Kenneth L. [1 ,2 ]
机构
[1] Baylor Coll Med, Texas Childrens Canc Ctr, Houston, TX 77030 USA
[2] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA
[3] Icahn Sch Med, Dept Oncol Sci, New York, NY USA
[4] Icahn Sch Med, Precis Immunol Inst, New York, NY USA
[5] Icahn Sch Med, Tisch Canc Inst, New York, NY USA
关键词
ERDHEIM-CHESTER DISEASE; PERIPHERAL LYMPHOID ORGANS; STEADY-STATE CONDITIONS; DENDRITIC CELLS; MUTATIONS; THERAPY; VEMURAFENIB; EXPRESSION; DISORDERS; NEOPLASMS;
D O I
10.1056/NEJMra1607548
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
[No abstract available]
引用
收藏
页码:856 / 868
页数:13
相关论文
共 99 条
[1]
How I treat Langerhans cell histiocytosis [J].
Allen, Carl E. ;
Ladisch, Stephan ;
McClain, Kenneth L. .
BLOOD, 2015, 126 (01) :26-35
[2]
Cell-Specific Gene Expression in Langerhans Cell Histiocytosis Lesions Reveals a Distinct Profile Compared with Epidermal Langerhans Cells [J].
Allen, Carl E. ;
Li, Liunan ;
Peters, Tricia L. ;
Leung, Hon-Chiu Eastwood ;
Yu, Alexander ;
Man, Tsz-Kwong ;
Gurusiddappa, Sivashankarappa ;
Phillips, Michelle T. ;
Hicks, M. John ;
Gaikwad, Amos ;
Merad, Miriam ;
McClain, Kenneth L. .
JOURNAL OF IMMUNOLOGY, 2010, 184 (08) :4557-4567
[3]
Neurodegenerative Central Nervous System Langerhans Cell Histiocytosis and Coincident Hydrocephalus Treated With Vincristine/Cytosine Arabinoside [J].
Allen, Carl E. ;
Flores, Ricardo ;
Rauch, Ronald ;
Dauser, Robert ;
Murray, Jeffrey C. ;
Puccetti, Diane ;
Hsu, David A. ;
Sondel, Paul ;
Hetherington, Maxine ;
Goldman, Stan ;
McClain, Kenneth L. .
PEDIATRIC BLOOD & CANCER, 2010, 54 (03) :416-423
[4]
Angeli Veronique, 2006, Lymphatic Research and Biology, V4, P217, DOI 10.1089/lrb.2006.4406
[5]
Controversies and new approaches to treatment of Langerhans cell histiocytosis [J].
Arceci, RJ ;
Brenner, MK ;
Pritchard, J .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 1998, 12 (02) :339-+
[6]
Langerhans cell histiocytosis in adults report from the International Registry of the Histiocyte Society [J].
Aricò, M ;
Girschikofsky, M ;
Généreau, T ;
Klersy, C ;
McClain, K ;
Grois, N ;
Emile, JF ;
Lukina, E ;
De Juli, E ;
Danesino, C .
EUROPEAN JOURNAL OF CANCER, 2003, 39 (16) :2341-2348
[7]
Targeted therapies in 54 patients with Erdheim-Chester disease, including follow-up after interruption (the LOVE study) [J].
Aubart, Fleur Cohen ;
Emile, Jean-Francois ;
Carrat, Fabrice ;
Charlotte, Frederic ;
Benameur, Neila ;
Donadieu, Jean ;
Maksud, Philippe ;
Idbaih, Ahmed ;
Barete, Stephane ;
Hoang-Xuan, Khe ;
Amoura, Zahir ;
Haroche, Julien .
BLOOD, 2017, 130 (11) :1377-1380
[8]
Recurrent BRAF mutations in Langerhans cell histiocytosis [J].
Badalian-Very, Gayane ;
Vergilio, Jo-Anne ;
Degar, Barbara A. ;
MacConaill, Laura E. ;
Brandner, Barbara ;
Calicchio, Monica L. ;
Kuo, Frank C. ;
Ligon, Azra H. ;
Stevenson, Kristen E. ;
Kehoe, Sarah M. ;
Garraway, Levi A. ;
Hahn, William C. ;
Meyerson, Matthew ;
Fleming, Mark D. ;
Rollins, Barrett J. .
BLOOD, 2010, 116 (11) :1919-1923
[9]
Langerhans cell histiocytosis: An evaluation of histopathological parameters, demonstration of proliferation by Ki-67 and mitotic bodies [J].
Bank, MI ;
Rengtved, P ;
Carstensen, H ;
Petersen, BL .
APMIS, 2003, 111 (02) :300-308
[10]
Multi-centre pilot study of 2-chlorodeoxyadeno sine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction [J].
Bernard, F ;
Thomas, C ;
Bertrand, Y ;
Munzer, M ;
Parker, JL ;
Ouache, M ;
Colin, VM ;
Perel, Y ;
Chastagner, P ;
Vermylen, C ;
Donadieu, J .
EUROPEAN JOURNAL OF CANCER, 2005, 41 (17) :2682-2689